A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread
Clinical trial NCT02060188 · COMPLETED
Trial details
- NCT number
- NCT02060188
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-12
- Primary completion
- 2024-10-22
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.